Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: University of California, Davis
Condition: Hormone-Resistant Prostate Cancer, Stage IV Prostate Adenocarcinoma
NCT02844582
Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: None
Stopped reason
Context when available
Poor accrual of subjects onto study